Enamel Matrix Derivative in the Treatment of Human Intrabony Osseous Defects

Authors:
  • MMManabu Momose
    Manabu Momose
  • AMAkira Miyazaki
    Akira Miyazaki
  • MMMasashi Murata
    Masashi Murata
  • SYShigeru Yokoyama
    Shigeru Yokoyama
  • YYYukari Yonezawa
    Yukari Yonezawa
  • LWLarry F. Wolff
    Larry F. Wolff
  • HYHiromasa Yoshie
    Hiromasa Yoshie

Abstract
Background: There is limited information available from clinical trials regarding the performance of enamel matrix derivative (EMD) in the treatment of periodontal intrabony defects. This randomized, double‐blind, placebo‐controlled, split‐mouth study was designed to compare the clinical and radiographical effects of EMD treatment to that of placebo‐controlled treatment for intrabony defects.Methods: Sixteen patients were included, each of whom had 1 or 2 pairs of intrabony defects located contralaterally in the same arch. Thirty‐six intrabony defects were randomly assigned treatment with flap surgery plus EMD or flap surgery plus placebo. At baseline and at the 12‐month follow‐up evaluation visit, clinical and radiographic measurements were determined. Data were statistically analyzed using the Wilcoxon‐signed rank test (α = 0.05).Results: At the 12‐month visit, bleeding on probing for the EMD group was 0.11 ± 0.32 compared to the placebo group, 0.61 ± 0.50 (P P P P P Conclusions: Treatment with flap surgery and EMD, compared to flap surgery with placebo, produced a significantly more favorable clinical improvement in intrabony periodontal defects. J Periodontol 2000;71:1821‐1828.

This publication has 35 references indexed in Scilit: